Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitex mixture versus cetirizine for urticaria
ChiCTR2300071435Phase 4Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitex agnus-castus fruit extract in urticaria (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Urticaria activity score within 7 days, Proportion of participants with UAS < 7 and 4 more. Started Jun 2022; status: recruiting.
02
Drugs
vitex agnus-castus fruit extract
03
Conditions
urticaria
Beyond the preview
Go deeper on ChiCTR2300071435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071435.